Gabriel Briones

Gabriel Briones

Auto-generated profile, based on publicly available information

Gabriel Briones

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2005 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BABeatriz Arellano-Reynoso
Beatriz Arellano-Reynoso
NLNicolas Lapaque
Nicolas Lapaque
SSSusana Salcedo
Susana Salcedo
GBGabriel Briones
Gabriel Briones
ACAndrés Eduardo Ciocchini
Andrés Eduardo Ciocchini
Jean-Pierre GorvelJean-Pierre Gorvel
Jean-Pierre Gorvel

3 July 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HNHiroyoshi Nishikawa
Hiroyoshi Nishikawa
ESEiichi Sato
Eiichi Sato
GBGabriel Briones
Gabriel Briones
LCLi-Mei Chen
Li-Mei Chen
MMMitsutoshi Matsuo
Mitsutoshi Matsuo
SGSacha Gnjatic
Sacha Gnjatic
Bacterial vectors may offer many advantages over other antigen delivery systems for cancer vaccines. We engineered a Salmonella typhimuriumvaccine strain to deliver the NY-ESO-1 tumor antigen (S. typhimurium–NY-ESO-1) through a type III protein secretion system. The S. typhimurium–NY-ESO-1 construct elicited NY-ESO-1–specific CD8+ and CD4+ T cells from peripheral blood lymphocytes ofcancer patients in vitro. Oral administration of S. typhimurium–NY-ESO-1 to mice resulted in the regression of established NY-ESO-1–expressing tumors. Intratumoral inoculation of S. typhimurium–NY-ESO-1 to NY-ESO-1–negative tumors resulted in delivery of antigen in vivo and led to tumor regression in the presence of preexisting NY-ESO-1–specific CD8+ T cells. Specific T cell responses against at least 2 unrelated tumor antigens not contained in the vaccine were observed, demonstrating epitope spreading. We propose that antigen delivery through the S. typhimuriumtype III secretion system is a promising novel strategy for cancer vaccine development.

1 July 2001 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
GBGabriel Briones
Gabriel Briones
NINora Iñón de Iannino
Nora Iñón de Iannino
MRMara Roset
Mara Roset
AVAna Vigliocco
Ana Vigliocco
PPPatricia Silva Paulo
Patricia Silva Paulo
RURodolfo A. Ugalde
Rodolfo A. Ugalde
Null cyclic β-1,2-glucan synthetase mutants ( cgs mutants) were obtained from Brucella abortus virulent strain 2308 and from B. abortus attenuated vaccinal strain S19. Both mutants show greater sensitivity to surfactants like deoxycholic acid, sodium dodecyl sulfate, and Zwittergent than the parental strains, suggesting cell surface alterations. Although not to the same extent, both mutants display reduced virulence in mice and defective intracellular multiplication in HeLa cells. The B. abortus S19 cgs mutant was completely cleared from the spleens of mice after 4 weeks, while the 2308 mutant showed a 1.5-log reduction of the number of brucellae isolated from the spleens after 12 weeks. These results suggest that cyclic β-1,2-glucan plays an important role in the residual virulence of the attenuated B. abortus S19 strain. Although the cgs mutant was cleared from the spleens earlier than the wild-type parental strain ( B. abortus S19) and produced less inflammatory response, its ability to confer protection against the virulent strain B. abortus 2308 was fully retained. Equivalent levels of induction of spleen gamma interferon mRNA and anti-lipopolysaccharide (LPS) of immunoglobulin G2a (IgG2a) subtype antibodies were observed in mice injected with B. abortus S19 or the cgs mutant. However, the titer of anti-LPS antibodies of the IgG1 subtype induced by the cgs mutant was lower than that observed with the parental S19 strain, thus suggesting that the cgs mutant induces a relatively exclusive Th1 response.

1 October 2006 in Infection and Immunity
Verified
Journal Article
Closed access
LCLi-Mei Chen
Li-Mei Chen
GBGabriel Briones
Gabriel Briones
RDRuben O. Donis
Ruben O. Donis
JGJorge E. Galán
Jorge E. Galán
Type III protein secretion systems, which are organelles with the capacity to deliver bacterial proteins into host cells, have been adapted to deliver heterologous antigens for vaccine development. A limitation of these antigen delivery systems is that some proteins are not amenable to secretion through this pathway. We show here that proteins from the simian and human immunodeficiency viruses that are not permissive for secretion through aSalmonella entericaserovar Typhimurium type III secretion system can be modified to travel this secretion pathway by introduction of discrete mutations. Proteins optimized for secretion were presented more efficiently via the major histocompatibility complex class I pathway and were able to induce a better immune response.

1 April 1997 in Microbiology
Verified
Journal Article
Closed access
GBGabriel Briones
Gabriel Briones
NLNora Iñón de Lannino
Nora Iñón de Lannino
MSMarcelo Steinberg
Marcelo Steinberg
RURodolfo A. Ugalde
Rodolfo A. Ugalde
Biosynthesis of periplasmic cyclic 1,2-β-glucans inBrucella ovisstrain REO198 andB. abortusstrain S19 was found to be carried out by membrane-bound enzymes that use UDP-glucose (UDP-Glc) as donor substrate. Contrary to what happens in species of the generaAgrobacteriumandRhizobium, the accumulation of the reaction products inBrucellaappeared not to be osmoticaliy regulated. Incubation of permeabilized cells with UDP-[14C]Glc led to the formation of soluble neutral cyclic 1,2-β-glucans and [14C]glucose-labelled glucoproteins. PAGE of pulse–chase experiments carried out with permeabilized cells showed that the molecular mass of the labelled protein was indistinguishable fromAgrobacterium tumefaciensA348 andRhizobium frediiUSDA191 glucoproteins known to be intermediates in the synthesis of cyclic glucans.Brucellatotal membrane preparations were less efficient than permeabilized cells in the formation of cyclic glucan; this was attributed to defective cyclization. Accumulation of protein intermediates having oligosaccharides of high molecular mass that were not released from the protein was observed after chase with 2 mM UDP-Glc. This defect was not observed when permeabilized cells were used as enzyme preparation, thus suggesting that inBrucellaa factor(s) that was lost or inactivated upon the preparation of membranes was required for the effective regulation between elongation and cyclization reactions.

1 September 2009 in Cell Host & Microbe
Verified
Journal Article
Closed access
RCRyan Chong
Ryan Chong
RSRachel Swiss
Rachel Swiss
GBGabriel Briones
Gabriel Briones
KSKathryn L. Stone
Kathryn L. Stone
EGErol E. Gulcicek
Erol E. Gulcicek
HAHervé Agaisse
Hervé Agaisse